NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Behçet’s disease is a chronic, relapsing, multisystem inflammatory disorder of unknown
etiology characterized by 4 major symptoms (oral aphthous ulcers, genital ulcers, skin
lesions, and ocular lesions) and occasionally by 5 minor symptoms (arthritis, gastrointestinal ulcers, epididymitis, vascular lesions, and central nervous system [CNS]
symptoms) (Cho, 2012). Juvenile idiopathic arthritis is a heterogeneous group of chronic inflammatory disorders
that initially presents in children by the age of 16 years. It refers to arthritis of at least
6 weeks duration of unknown etiology that begins in children less than 16 years old.
Juvenile idiopathic arthritis has an annual incidence of 2 to 20 cases per 100 000
population and a prevalence of 16 to 150 cases per 100 000 population. It is an
autoimmune disorder marked by abnormalities of immune responses (Adelowo, 2010).
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.